More articles from Commentary
- Malfunctions in implantable cardiac devices: Putting the risk in perspective
A device recall does not call for panic. Physicians should weigh the risks and benefits for the individual patient.
- The authors reply: Shared appointments can be good care
Shared appointments are not for everybody, but we have found they help in providing access for hopelessly backlogged physicians and are usually enjoyable for both the patients and the physician.
- ‘Thanks for sharing’: A fictional reflection on shared medical appointments
“I’m not an exhibitionist, Doctor. I came here to see you, not to be part of a medical encounter group.”
- The sad story of Vioxx, and what we should learn from it
The withdrawal of rofecoxib (Vioxx) has important implications both for patients with arthritis and for the pharmaceutical field in general.
- A world without Vioxx: To COX-2 or not to COX-2?
Are all selective COX-2 inhibitors associated with an increased risk for thromboembolic cardiovascular events? And what should we tell patients?
- It’s what’s inside the white coat that counts
Welcoming the first class of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
- Genetic discrimination arising from cancer risk assessments: A societal dilemma
The right to privacy of one’s most intimate biological secrets must be affirmed.
- The needs of science vs the needs of patients: Ethical concernsin cancer clinical trials
Patients in cancer trials are not data points; they are vulnerable people who often view a clinical trial as their last hope.
- Privacy protection for your patients: Understanding the federal requirements
On April 14, 2003, almost every medical provider in this country must implement new federal privacy rules. Here’s how.